Independent public reference library

Ageing biology, biomarkers, interventions, and research literacy.

Resting Heart Rate and Biological Age

Key Takeaways

Resting heart rate is the number of heartbeats per minute measured when a person is awake, inactive, and physiologically settled. It is a simple measurement, but its value emerges from several interacting systems rather than from cardiac ageing alone. [1] [2]

Who This Is Useful For

This page is useful for readers interpreting resting pulse measurements, population studies, or claims that a low or high heart rate reveals a person's biological age. It explains what the measure captures, why it predicts some outcomes, and why it cannot be translated directly into “years younger” or “years older.”

What Resting Heart Rate Measures

The sinoatrial node generates the heart's intrinsic rhythm, while parasympathetic and sympathetic input continually modify that rhythm. Circulating hormones, body temperature, metabolic demand, blood volume, cardiac function, and physical conditioning also influence the observed rate. Resting heart rate is therefore an integrated physiological signal, not a direct assay of one pathway. [1] [2]

It is also different from heart rate variability and heart rate recovery. Resting heart rate summarizes average frequency in a baseline state; variability describes beat-to-beat timing, while recovery describes the dynamic fall after exercise. These measures overlap biologically but are not interchangeable. [2] [3]

Why It Is Relevant to Biological Age

A useful ageing biomarker should capture biologically meaningful variation beyond chronological age and relate reproducibly to later function or outcomes. Resting heart rate partly meets the outcome criterion: prospective cohorts repeatedly associate higher values with higher mortality risk. It is less specific to ageing biology because disease burden, fitness, medication, smoking, inflammation, and other factors can shift the same measurement. [4] [5]

Chronological age does not map onto resting heart rate in a simple linear way. In a large 2025 analysis, the prevalence of a resting rate of 80–99 beats per minute changed little across adult age groups even though its association with mortality persisted. This illustrates the difference between a risk marker and a clock: a variable can predict outcomes without steadily tracking elapsed age. [6]

Interpretation at a Glance

QuestionWhat the Evidence SupportsImportant Qualification
Physiological meaningAn integrated signal influenced by autonomic and cardiovascular regulationIt does not isolate one ageing mechanism
Population riskHigher values are associated with greater all-cause and cardiovascular mortalityThresholds and effect sizes vary across cohorts
Chronological ageAge can alter autonomic cardiovascular regulationResting rate does not rise uniformly with adult age
Biological ageIt may add information to multivariable or organ-specific modelsIt is not a standalone ageing clock
Longitudinal changeRising values over years have been associated with adverse outcomesA change does not identify its underlying cause

Evidence From Population Studies

A meta-analysis of 46 prospective studies, including more than 1.2 million participants for the all-cause mortality analysis, reported higher relative risk with each 10-beat-per-minute increment. Substantial heterogeneity and evidence of publication bias were also present, so the pooled estimate should not be treated as universal across populations. [4]

Individual cohorts reinforce both the signal and its non-specificity. In the Copenhagen City Heart Study, resting heart rate remained associated with cardiovascular and all-cause mortality after adjustment for inflammatory markers. In NHANES III, associations were observed for cardiovascular and non-cardiovascular mortality, leading the investigators to interpret the measure as a marker of broader health rather than cardiovascular health alone. [5] [7]

Longitudinal Change

Repeated measurements may contain information that a single baseline value misses. In the ARIC cohort, time-updated resting heart rate and increases between visits were associated with mortality and several cardiovascular outcomes after adjustment for established risk factors and medications. Analyses of the Paris Prospective, Whitehall, and Framingham studies likewise associated increases over several years with higher mortality risk. [8] [9]

These findings do not show that lowering the number itself reverses biological ageing. A rising rate could be a downstream sign of changing fitness, illness, medication, autonomic regulation, or other processes. Longitudinal association improves temporal information but does not by itself establish mechanism or causality. [8] [9]

Brain Age and Other Age-Gap Models

Emerging studies have tested resting heart rate against machine-learning estimates of organ age. In a UK Biobank analysis, higher baseline resting heart rate was associated with an older MRI-derived brain age and a larger brain-age gap. The design was observational, and the higher-rate groups also differed in health and behavioural characteristics; the result therefore supports association, not a direct measurement of brain ageing or proof of causation. [10]

An age gap is itself a model-dependent estimate. An association with one brain-age algorithm does not make resting heart rate a whole-body biological clock, and it does not establish equivalence with epigenetic, proteomic, functional, or clinical ageing measures. [10]

Measurement and Context

Comparisons require similar conditions. Electrocardiography, a pulse sensor, and manual pulse counting can estimate average rate, but posture, rest duration, recording length, time of day, recent exertion, stimulants, temperature, hydration, and emotional arousal can alter the result. Rhythm disturbances and signal artefacts can also make a device-reported average misleading. [2] [3]

Medication is especially important for biological-age interpretation. Beta-blockers and some calcium channel blockers directly alter heart rate, while thyroid disease, infection, anaemia, cardiovascular disease, and other conditions can affect it through different mechanisms. Similar numbers can therefore arise from very different physiological states. [1] [2]

Evidence Quality and Interpretation

Confidence is moderate to strong that higher resting heart rate is a population-level prognostic marker for mortality. Confidence is lower about a specific causal pathway because prospective studies retain residual confounding, pooled estimates are heterogeneous, and cardiovascular and non-cardiovascular outcomes both contribute to the association. [4] [7]

Confidence is currently low that resting heart rate alone measures biological age. Its broad physiological sensitivity can make it informative within a larger assessment, but the same property limits specificity. Organ-age findings are promising research observations rather than validation of a clinically interpretable ageing clock. [6] [10]

What This Does Not Mean

Practical Interpretation Examples

Related Reading

Summary

Resting heart rate is an accessible integrated measure of cardiovascular, autonomic, and metabolic state. Higher and rising values are associated with adverse outcomes in many cohorts, but the measure is non-specific and does not track chronological age in a clock-like fashion. It is best understood as contextual physiological and prognostic information, not a standalone estimate of biological age. [4] [6] [9]

References

  1. Fox, K., Borer, J. S., Camm, A. J., et al. (2007). Resting heart rate in cardiovascular disease. Journal of the American College of Cardiology, 50(9), 823-830. https://pubmed.ncbi.nlm.nih.gov/17719466/
  2. Cooney, M. T., Vartiainen, E., Laatikainen, T., Juolevi, A., Dudina, A., & Graham, I. M. (2010). Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. American Heart Journal, 159(4), 612-619.e3. https://pubmed.ncbi.nlm.nih.gov/20362720/
  3. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability: standards of measurement, physiological interpretation and clinical use. European Heart Journal, 17(3), 354-381. https://pubmed.ncbi.nlm.nih.gov/8737210/
  4. Zhang, D., Shen, X., & Qi, X. (2016). Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ, 188(3), E53-E63. https://pubmed.ncbi.nlm.nih.gov/26598376/
  5. Jensen, M. T., Marott, J. L., Allin, K. H., Nordestgaard, B. G., & Jensen, G. B. (2012). Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. European Journal of Preventive Cardiology, 19(1), 102-108. https://pubmed.ncbi.nlm.nih.gov/21525123/
  6. Wen, C. P., Chen, C. H., Nauman, J., et al. (2025). Resting heart rate—the forgotten risk factor? Comparison of resting heart rate and hypertension as predictors of all-cause mortality in 692,217 adults in Asia and Europe. Progress in Cardiovascular Diseases, 88, 64-73. https://pubmed.ncbi.nlm.nih.gov/39894380/
  7. Alhalabi, L., Singleton, M. J., Oseni, A. O., et al. (2017). Relation of higher resting heart rate to risk of cardiovascular versus noncardiovascular death. American Journal of Cardiology, 119(7), 1003-1007. https://pubmed.ncbi.nlm.nih.gov/28132682/
  8. Vazir, A., Claggett, B., Cheng, S., et al. (2018). Association of resting heart rate and temporal changes in heart rate with outcomes in participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiology, 3(3), 200-206. https://pubmed.ncbi.nlm.nih.gov/29365021/
  9. Gaye, B., Valentin, E., Xanthakis, V., et al. (2024). Association between change in heart rate over years and life span in the Paris Prospective 1, the Whitehall 1, and Framingham studies. Scientific Reports, 14, 20052. https://pubmed.ncbi.nlm.nih.gov/39209972/
  10. He, D., Zhang, J., Zhang, Y., et al. (2024). Association between resting heart rate and machine learning-based brain age in middle- and older-age. Journal of Alzheimer's Disease, 100(3), 997-1007. https://pubmed.ncbi.nlm.nih.gov/39044526/
Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice.